EAU Prostate Cancer Risk Groups

ورودی‌های بالینی بیمار

حداقل ۰.۱ — حداکثر ۲۰۰ • واحد: ng/mL

حداقل ۱ — حداکثر ۵

پنل نتیجه و تصمیم بالینی
در انتظار ورودی‌ها
risk group
—group
آماده برای ارزیابی

پارامترهای بالینی بیمار را در فرم روبرو وارد کنید و روی «محاسبه» کلیک نمایید تا نمره، طبقه خطر و اقدامات فوری نمایش داده شوند.

طبقات خطر و بازه‌های امتیاز:
  • grouped≥ 0
Direct Clinical Answer

The EAU Prostate Cancer Risk Groups calculates evaluating lower urinary tract symptoms, nephrolithiasis burden, and prostate cancer risk. Key inputs include psa. Scores guide initiating medical expulsive or alpha-blocker therapy, ordering renal imaging, or scheduling surgical intervention. This standardized assessment improves clinical decision safety and bedside patient management.

Clinical Guidelines & Evidence

EAU localized prostate cancer risk stratification.

Clinical Indication

The EAU Prostate Cancer Risk Groups is indicated for bedside clinical practice to support EAU localized prostate cancer risk stratification.. It assists healthcare providers in standardizing clinical assessment and therapeutic decision-making.

Target Population

Target population comprises Patients presenting with renal colic, hematuria, benign prostatic hyperplasia (BPH), or urogenital malignancies. Clinical application is indicated across Urology clinics, shock wave lithotripsy suites, and acute urologic surgical services.

Limitations & Contraindications

Serum PSA levels can be transiently elevated by acute prostatitis, urinary retention, or recent instrumentation.

Clinical Pearls & Action Plan

Obstructive urolithiasis complicated by upper urinary tract infection represents a surgical emergency requiring urgent decompression.

Formula & Variables:

Low: PSA<10 and ISUP 1 and cT1-2a; Intermediate: PSA 10-20 or ISUP 2-3 or cT2b; High: PSA>20 or ISUP 4-5 or cT2c+

Input Parameters

NameTypeRequiredDescription
psafloatYesPSA(ng/mL)
isupintegerYesISUP grade group

Score Interpretation & Guidance

RangeStageDescription
≥ 0groupedRisk group

Evidence-Based References (EBM)

  • Mottet N, et al. EAU Guidelines on Prostate Cancer. 2023 update.

Related calculators